EGFR and lung carcinoma: ✓ Aberrant methylation at the promoter region of RASSF1A and GADD45β inversely correlates with protein expression and is linked to the acquisition of TKI resistance in lung cancer cells.✓ Cell treatment with 5-Aza-CdR could partially restore the sensitivity of cells to EGFR-TKI.